Apollo Care, LLC recalls SEMAGLUTIDE 2.25MG (0.9 mg/mL)
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
- Products
-
- SEMAGLUTIDE 2.25MG (0.9 mg/mL)
- Company
- Apollo Care, LLC
- Where it was sold
-
Nationwide within the U.S
Nationwide
- Units affected
- 23,029 vials.
- About this recall
- SEMAGLUTIDE 2.25MG (0.9 mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202 NDC 71170-811-02